intermediate AMD
Jun 07, 2024
Dry AMD Treatment- An Underserved Market With Billion-Dollar Potential
Wet AMD, comprising around 10% of the total AMD population, is primarily the target of pharmaceutical companies, representing a market worth billions of dollars. With only two FDA-approved treatments, dry AMD presents a substantial market potential, encompassing approximately 90% of all AMD patients. Key players...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
